Investment Trend Shift: Backers of dYdX (ethDYDX) and Injective (INJ) Now Eyeing an Emerging Contender

Businessman following coins on the phone. coin and analytics chart. coin exchangeThe recent market fluctuations and challenges faced by top altcoins like dYdX (ethDYDX) and Injective (INJ) have sparked a shift in investor interest, leading backers of these established tokens to now turn their attention towards an emerging contender, VC Spectra (SPCT).

But why are they shifting their focus to SPCT? Let’s explore the details!

>>BUY SPCT TOKENS NOW<<

Market Fluctuations Dampens dYdX’s (ethDYDX) v4 Launch

On December 2, 2023, the dYdX Foundation made an exciting announcement through X about the release of dYdX v4. This launch has generated a lot of optimism for dYdX (ethDYDX), as staking yields have already increased by approximately 10%. The project is expected to experience further growth as volume shifts from v3 to v4.

The news had a positive impact on the value of dYdX (ethDYDX), resulting in an 8.10% increase. Between December 2 and 4, the price of dYdX (ethDYDX) rose from $3.09 to $3.51.

However, the price momentum of dYdX has been hindered by market volatility. As a result, the price of dYdX (ethDYDX) gradually declined by 6%, reaching $2.89 on December 6.

Furthermore, analysts predict that if market conditions remain volatile, dYdX (ethDYDX) may continue to fall in price. They anticipate that the altcoin price will drop to $2.50 in December.

Injective (INJ) Struggles To Maintain Gains Amid Market Turmoil

On November 30, 2023, Injective (INJ) made a significant announcement regarding its Volan upgrade, which is being hailed as the most extensive mainnet update in the eco’s history.

The news generated a wave of excitement within the Injective community, leading to a 2% increase in its value. Within 24 hours, the price of Injective (INJ) rose from $16.74 to $18.84.

However, the initial surge in Injective’s (INJ) value was short-lived as market turbulence caused a reversal of gains and a subsequent downward trend. Between November 30 and December 6, the price of Injective (INJ) experienced a decline of 6%, reaching a value of $16.95.

Furthermore, prevailing technical indicators suggest that the current sentiment surrounding Injective remains bearish. As a result, analysts anticipate a further decrease in the price of Injective (INJ) to $15.03 in December, making it not a good crypto to buy now.

VC Spectra (SPCT) Shakes Up Crypto Market With Explosive Growth

The investment landscape in the crypto world is witnessing a significant shift as backers of established tokens like dYdX (ethDYDX) and Injective (INJ) are now turning their attention towards an emerging contender called VC Spectra (SPCT).

VC Spectra (SPCT) has managed to capture the interest of investors by offering valuable investment and trading insights. Leveraging its expertise in the blockchain and fintech sectors, the platform empowers users to identify and capitalize on lucrative opportunities, positioning itself as one of the top DeFi projects in the market.

The key focus of VC Spectra (SPCT) lies in utilizing momentum trading strategies, including technical analysis and ious indicators, to identify tokens that are likely to experience upward or downward momentum. By leveraging market trends, investors can potentially maximize their returns and take advantage of favorable market conditions.

Moreover, the current price of VC Spectra (SPCT) in Stage 5 of its public presale stands at $0.077, showcasing an astonishing increase of 862.5% from its Stage 1 price of $0.008. This exponential growth not only reflects the high demand for SPCT but also indicates its potential to surpass its target price of $0.080. If SPCT manages to achieve this, investors could see a remarkable ROI of over 900% by the end of the presale.

Learn more about VC Spectra (SPCT) and its presale:

Buy Presale:

Website:

Telegram:

Twitter: